Disclosures for "Impact of a Free Anti-seizure Medication Intervention on Anxiety and Depression in People Living with Epilepsy in the Republic of Guinea")
-
Mr. Rice has nothing to disclose.
-
Guelngar Carlos Othon has nothing to disclose.
-
Dr. Traore has nothing to disclose.
-
Mohamed Lamine Conde has nothing to disclose.
-
Miss Diallo has nothing to disclose.
-
Dr. Lee has nothing to disclose.
-
Fode Abass Cisse has nothing to disclose.
-
Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from NIH. The institution of Dr. Mateen has received research support from Sumaira Foundation. The institution of Dr. Mateen has received research support from EMD Serono. Dr. Mateen has received research support from Biogen.